» Articles » PMID: 37298715

Cyanidin-3-O-glucoside As a Nutrigenomic Factor in Type 2 Diabetes and Its Prominent Impact on Health

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Jun 10
PMID 37298715
Authors
Affiliations
Soon will be listed here.
Abstract

Type 2 diabetes (T2D) accounts for a global health problem. It is a complex disease as a result of the combination of environmental as well as genetic factors. Morbidity is still increasing across the world. One of the possibilities for the prevention and mitigation of the negative consequences of type 2 diabetes is a nutritional diet rich in bioactive compounds such as polyphenols. This review is focused on cyanidin-3-O-glucosidase (C3G), which belongs to the anthocyanins subclass, and its anti-diabetic properties. There are numerous pieces of evidence that C3G exerts positive effects on diabetic parameters, including in vitro and in vivo studies. It is involved in alleviating inflammation, reducing blood glucose, controlling postprandial hyperglycemia, and gene expression related to the development of T2D. C3G is one of the beneficial polyphenolic compounds that may help to overcome the public health problems associated with T2D.

Citing Articles

Anthocyanins and Type 2 Diabetes: An Update of Human Study and Clinical Trial.

Kozlowska A, Nitsch-Osuch A Nutrients. 2024; 16(11).

PMID: 38892607 PMC: 11174612. DOI: 10.3390/nu16111674.

References
1.
Guo X, Yang B, Tan J, Jiang J, Li D . Associations of dietary intakes of anthocyanins and berry fruits with risk of type 2 diabetes mellitus: a systematic review and meta-analysis of prospective cohort studies. Eur J Clin Nutr. 2016; 70(12):1360-1367. DOI: 10.1038/ejcn.2016.142. View

2.
Yeung A, Tzvetkov N, Durazzo A, Lucarini M, Souto E, Santini A . Natural products in diabetes research: quantitative literature analysis. Nat Prod Res. 2020; 35(24):5813-5827. DOI: 10.1080/14786419.2020.1821019. View

3.
Morris A, Voight B, Teslovich T, Ferreira T, V Segre A, Steinthorsdottir V . Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012; 44(9):981-90. PMC: 3442244. DOI: 10.1038/ng.2383. View

4.
Dryden G, Song M, McClain C . Polyphenols and gastrointestinal diseases. Curr Opin Gastroenterol. 2006; 22(2):165-70. PMC: 4216723. DOI: 10.1097/01.mog.0000208463.69266.8c. View

5.
Wang L, Waltenberger B, Pferschy-Wenzig E, Blunder M, Liu X, Malainer C . Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review. Biochem Pharmacol. 2014; 92(1):73-89. PMC: 4212005. DOI: 10.1016/j.bcp.2014.07.018. View